Biotech · Private company · Woodcliff Lake, NJ, US

Eagle Pharmaceuticals, Inc.

SEC CIK 0000827871

Track this companyFree. Adds Eagle Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials52 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline5

CAL02Phase 2 · Pneumonia, BacterialClinicalTrials.gov · fetched Nov 12, 2026
Ryanodex (dantrolene sodium) for injectable suspensionPhase 2 · Drug Toxicity Psychotropic Agents PsychostimulantsClinicalTrials.gov · fetched Nov 12, 2026
Faslodex (Reference)Phase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
Fulvestrant for Injectable SuspensionPhase 1 · PharmacokineticsClinicalTrials.gov · fetched Nov 12, 2026
Test Product (Bendamustine)Phase 1 · Cancer Which Has Either Progressed or Relapsed After Standard Therapy, or for Which no Curative or Standard Therapy is AppropriateClinicalTrials.gov · fetched Nov 12, 2026

Study of Remimazolam for Cataract SurgeryPHASE4 · NOT_YET_RECRUITING · started Sep 15, 2026ClinicalTrials.gov NCT07325227 · fetched Nov 12, 2026
Blinded Efficacy and Safety Study of CAL02 IV Plus SOC in Subjects With Severe Community-Acquired Bacterial PneumoniaPHASE2 · ACTIVE_NOT_RECRUITING · started Jul 22, 2023ClinicalTrials.gov NCT05776004 · fetched Nov 12, 2026
Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM AdministrationPHASE1 · COMPLETED · started Nov 30, 2017ClinicalTrials.gov NCT03324061 · fetched Nov 12, 2026
Efficacy and Safety Study of Ryanodex as Adjuvant Treatment in Subjects With Psychostimulant Drug-Induced Toxicity (PDIT)PHASE2 · TERMINATED · started Aug 12, 2017ClinicalTrials.gov NCT03189433 · fetched Nov 12, 2026
A Phase I, Bioequivalence Study to Evaluate Two Formulations of Bendamustine (BDM) Hydrochloride (HCl) Administered to Cancer PatientsPHASE1 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT02162888 · fetched Nov 12, 2026